The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
Marsha M van OostwaardCaroline E WyersJohanna H M DriessenMaud van MarenMarc de JongAgnes J van de WouwMaryska L G Janssen-HeijnenJoop P van den BerghPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
Current ADT use was associated with a higher risk of fragility fractures than no-ADT use. A higher fracture risk was observed within the first six months of ADT use and persisted for longer durations.